VLDLR and Sepsis: PCSK9 is also involved in the degradation of the VLDL receptor [64] and adipose tissue may play a secondary role in the removal of lipopolysaccharide via VLDL receptor uptake [65], which may explain why sepsis prognosis is better in obese patients [7,66].